Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ABO1009-DP / Suzhou Abogen Biosci
NCT05433194: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)	Active, not recruiting	1/2	48	RoW	ABO1009-DP	Suzhou Abogen Biosciences Co., Ltd.	COVID-19	09/22	08/23
NCT05434585: A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines	Active, not recruiting	1	60	RoW	ABO1009-DP, ABO-CoV.617.2, Placebo	Suzhou Abogen Biosciences Co., Ltd.	COVID-19	10/22	08/23